Freshfields advised Kartesia on financing for Jecture

Global law firm Freshfields has advised Kartesia Management S.à r.l. and affiliated funds on a refinancing for Jecture group, a portfolio company of Gilde Healthcare Private Equity and European leader in precision medical components and injection technology, formed through the merger of Acti-Med and Europin, with manufacturing operations across Germany, Poland and Slovakia.

Headquatered in Utrecht, Netherlands, Gilde Healthcare is a specialized investor managing €3bn across three strategies: Venture & Growth in healthcare, Private Equity in healthcare and Climate Solutions. It invests in digital health, medtech and therapeutics companies in Europe and North America, as well as profitable lower mid-market healthcare and climate-focused companies in the Benelux, Nordics and DACH region.

Freshfields has recently advised Kartesia on a hybrid financing for AndCompany.

The Freshfields team advising Kartesia included Partner Michael Josenhans as well as Associates Alexander Bräuer (both Frankfurt) and Karl Kuhn (Berlin, all Finance).